Register your cosmetic facility, maintain annual U.S. Agent representation for foreign facilities, prepare product listings, and keep your U.S. cosmetics compliance organized through FDA's current Cosmetics Direct process.
Direct answer: Under MoCRA, many domestic and foreign cosmetic manufacturers and processors must register their facilities with FDA. FDA facility registration renews every two years, while cosmetic product listings are updated annually. Foreign facilities must provide U.S. Agent contact information. FDA Registration Assistance's U.S. Agent service is an annual professional service, so our $849 service renews each year even though the FDA facility-registration filing cycle is biennial. See FDA's current registration and listing requirements.
MoCRA separates facility-level obligations from product-level obligations. Understanding which role belongs to the facility, the Responsible Person, or the foreign facility's U.S. Agent prevents incorrect registrations and duplicate filings.
Facilities subject to MoCRA registration provide facility, owner/operator, product-category, brand, Responsible Person, and other required information to FDA. FDA uses the FEI as the facility registration number.
The Responsible Person lists marketed cosmetic products, including required ingredient and facility information, and provides annual updates through the FDA product-listing process.
Foreign facilities provide U.S. Agent contact information with the facility registration. Our U.S. Agent representation is maintained as an annual service so there is an active U.S. compliance contact year-round.
The Responsible Person must ensure adequate substantiation of cosmetic-product safety and maintain records supporting the product's safe use under labeled or customary conditions.
MoCRA created serious adverse event reporting and recordkeeping duties. Complaint handling and escalation procedures should be organized before products are broadly marketed.
Cosmetic labeling still must comply with applicable FD&C Act and 21 CFR Part 701 requirements. Drug claims can change a cosmetic's regulatory status and trigger additional requirements.
Our professional service fees are separate from FDA government charges. The annual U.S. Agent service term is also separate from FDA's biennial facility-registration renewal cycle.
Product listing is a separate filing made for marketed cosmetic products by the Responsible Person. Annual updates are required.
We organize the facility, identifier, U.S. Agent, and product information before submission so the filing reflects the correct legal entity and regulatory role.
Send the legal facility name, physical address, contact details, ownership information, product categories, brands, and foreign-facility details if applicable.
We confirm the facility identifier and review the data needed for Form FDA 5066. DUNS is not treated as a mandatory MoCRA identifier.
We prepare the facility-registration information and support filing through FDA's current Cosmetics Direct workflow.
For foreign facilities, annual U.S. Agent service continues year-round. We also track the facility's biennial FDA renewal and related update needs.
These are three different compliance functions. Businesses exporting cosmetics to the United States may need all three, but each one has a different responsible party and renewal/update cycle.
FDA updated Cosmetics Direct in February 2026 to support the first wave of biennial cosmetic-facility renewals and now displays registration status and renewal-date information in the portal.
FDA states that a cosmetic facility's registration is renewed every two years from its initial registration date. This is different from the old page's annual-renewal language. Product listings remain annual. For foreign facilities, our U.S. Agent professional service still renews every year.
These services are directly connected to cosmetic facility registration, product listing, and ongoing U.S. market compliance.
Prepare and submit cosmetic product listings for marketed products and coordinate annual listing updates.
View service →Annual U.S. Agent representation for foreign cosmetic facilities registered under MoCRA.
View service →Review identity statements, net contents, responsible-party information, ingredients, warnings, and claims before U.S. distribution.
View service →Optional DUNS support when your company needs the identifier for business or other compliance purposes. DUNS is not currently mandatory on Form FDA 5066.
View service →Obtain organized documentation reflecting your registration or listing records. This is not FDA product approval or an FDA-issued approval certificate.
View service →Evaluate and complete applicable California cosmetic reporting requirements separately from federal MoCRA obligations.
View service →MoCRA compliance is easier to maintain when the facility registration, U.S. Agent, product listings, and labeling records are coordinated instead of handled as disconnected tasks.
We separate facility obligations, Responsible Person obligations, and U.S. Agent responsibilities so the correct legal entity is used in each filing.
Our page and filing workflow use FDA's current biennial facility-renewal cycle, annual product-listing updates, and FEI-based facility registration.
Foreign facilities can maintain one annual service relationship for ongoing U.S. Agent representation rather than searching for a contact only when a filing becomes due.
We provide organized compliance documentation without implying that registration or listing equals FDA product approval.
Direct answers to the questions cosmetic manufacturers, foreign facilities, contract manufacturers, and brand owners ask most often before entering or maintaining the U.S. market.
FDA cosmetic facility registration is the mandatory registration required for many facilities that manufacture or process cosmetic products for distribution in the United States. The requirement comes from the Modernization of Cosmetics Regulation Act of 2022 (MoCRA).
Generally, domestic and foreign facilities that manufacture or process cosmetic products for U.S. distribution must register unless a statutory exemption applies. Certain small businesses may be exempt, but the exemption does not apply to specified higher-risk product categories.
FDA requires cosmetic facility registration to be renewed every two years from the date of initial registration. Facility registration information also must be updated within 60 days of certain changes. See FDA's current instructions.
The FDA filing cycle and the professional U.S. Agent service term are separate. FDA cosmetic facility registration is renewed every two years, but FDA Registration Assistance provides ongoing U.S. Agent representation and compliance support as an annual service, so the $849 professional service renews each year.
Yes. Foreign cosmetic facilities that are required to register must provide U.S. Agent contact information as part of Form FDA 5066. FDA Registration Assistance offers annual U.S. Agent representation for foreign cosmetic facilities.
No. FDA currently lists the facility DUNS number as optional on Form FDA 5066. The required facility registration number is the FDA Establishment Identifier (FEI), which should be obtained before the facility registration is submitted.
The FDA Establishment Identifier (FEI) is the facility registration number FDA uses for cosmetic product facility registration. FDA states that the owner or operator should obtain an FEI before submitting the facility registration.
A Responsible Person must provide updates to each cosmetic product listing annually. FDA Form 5067 includes annual update and abbreviated renewal options.
FDA Registration Assistance charges $849 per year for its professional MoCRA facility registration and compliance service. For foreign facilities, the annual service includes ongoing U.S. Agent representation. FDA does not charge a government filing fee for MoCRA cosmetic facility registration.
FDA Registration Assistance charges $200 per cosmetic product listing. FDA does not currently charge a government filing fee for the MoCRA product listing submission itself.
No. Facility registration, product listing, an FEI, or a listing confirmation does not mean FDA has approved, endorsed, or certified the cosmetic product. Cosmetics generally are not preapproved by FDA, except that certain color additives require approval for their intended uses.
Some small businesses may qualify for an exemption based on average U.S. cosmetic sales, adjusted for inflation, but the exemption does not apply to specified product categories such as certain products used around the eye, injected products, internal-use products, or products intended to alter appearance for more than 24 hours under the statutory conditions.
Facility registration identifies the manufacturing or processing facility. Product listing identifies each marketed cosmetic product and is submitted by the Responsible Person. A company may have obligations under both requirements, but they are separate filings.
The Responsible Person is the manufacturer, packer, or distributor whose name appears on the cosmetic product label in accordance with applicable U.S. labeling law. The Responsible Person is responsible for cosmetic product listing and other MoCRA duties tied to the product.
Cosmetics Direct is FDA's electronic submission portal for cosmetic facility registration and cosmetic product listing. FDA also permits other submission methods described in its current registration and listing materials.
Common required information includes the facility's legal name, physical address, FEI number, phone and email, owner or operator information, cosmetic product brand names, Responsible Person information, product category codes, and U.S. Agent contact information for a foreign facility.
Yes. FDA provides Cosmetics Direct and other submission methods for businesses that choose to self-file. Professional assistance can be useful when you want help reviewing facility information, FEI details, U.S. Agent information for a foreign facility, product categories, and submission records before filing.
Timing depends on whether the required facility information and FEI are already available and on FDA processing. Once we have complete information, we prepare and submit the filing promptly, but FDA processing time is outside our control and we do not represent a filing as approved until the applicable FDA confirmation is available.
The Responsible Person must report a serious adverse event associated with use of a cosmetic product in the United States to FDA within 15 business days. The report must include a copy of the label on or within the retail packaging. Certain follow-up information received within one year must also be submitted to FDA within 15 business days.
The Responsible Person must ensure and maintain records supporting adequate substantiation of safety for each cosmetic product. FDA does not prescribe one specific test for every cosmetic; scientifically robust existing data, studies, analyses, and other appropriate evidence may be used to support safety.
Cosmetic labeling must comply with applicable U.S. requirements, including an identity statement, net quantity of contents, the name and place of business, and an ingredient declaration where required. Required label information generally must appear in English and be prominent and conspicuous. Products that are also drugs have additional requirements.
Yes. Imported cosmetics must comply with the same U.S. laws and regulations that apply to domestically produced cosmetics. Depending on the business and product, that can include MoCRA facility registration, product listing, U.S. Agent information for a foreign facility, labeling, ingredient, and safety requirements.
Selling online does not by itself make a company a cosmetic manufacturing facility. Facility registration obligations depend on whether the business manufactures or processes cosmetics, while product listing obligations generally fall on the Responsible Person whose name appears on the label. We can review the roles in your supply chain before determining which filings apply.
FDA classification depends on intended use. Products intended to cleanse, beautify, promote attractiveness, or alter appearance are generally cosmetics; products intended to diagnose, treat, mitigate, or prevent disease or affect the structure or function of the body are drugs. A product can be both. The term “cosmeceutical” has no legal meaning under the FD&C Act.
Send us your facility and product information. We will review which MoCRA filings apply, confirm the required identifiers, and explain the annual U.S. Agent service separately from FDA's biennial facility-registration renewal.
Prefer to contact us directly?
Tell us what you need and a compliance specialist will review your inquiry.
Thank you. Your cosmetic compliance inquiry was submitted successfully and our team will review the information provided.
